ArticleJournal of clinical medicine2022

CD24 Is a Prognostic Marker for Multiple Myeloma Progression and Survival.

Noa Gross Even-Zohar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.